NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Comparison of serum and heparinized plasma samples for measurement of chemistry analytes.

Author(s): Miles RR, Roberts RF, Putnam AR, Roberts WL

Publication: Clin Chem, 2004, Vol. 50, Page 1704-6

PubMed ID: 15331516 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of analyzing serum versus heparinized plasma on the measurements of 45 clinical chemistry analytes. For a subset of analytes, the results from two different analyzers were also compared.

Conclusion of Paper

Heparinized plasma had significantly lower levels of bile acids (-67%) and potassium (-6.0%) and higher levels of aldolase (+39%), ACE (+22%), and lactate dehydrogenase (+21%) than serum when measured on the Roche analyzer. Potassium and lactate dehydrogenase levels showed similar differences to those observed with the Roche analyzer between heparinized plasma and serum when measured by the Vitros 950 analyzer. However, the Vitros 950 analyzer also measured 20% higher bilirubin levels in plasma than serum. Importantly, the manufacturers of each analyzer state that both heparinized plasma and serum are acceptable for these assays where significant differences were found.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of analyzing serum versus heparinized plasma on the measurements of 45 clinical chemistry analytes. For a subset of analytes, the results from two different analyzers were also compared. For all twenty volunteers, serum tubes were filled prior to lithium-heparin tubes after a single venipuncture. Serum and plasma were stored at -70 degrees C for up to 8 months prior to analysis.

    Summary of Findings:

    Heparinized plasma had significantly lower levels of bile acids (-67%) and potassium (-6.0%) and higher levels of aldolase (+39%), ACE (+22%), and lactate dehydrogenase (+21%) than serum when measured on the Roche analyzer. Potassium and lactate dehydrogenase levels showed similar differences to those observed with the Roche analyzer between heparinized plasma and serum when measured by the Vitros 950 analyzer. However, the Vitros 950 analyzer also measured 20% higher bilirubin levels in plasma than serum. Importantly, the manufacturers of each analyzer state that both heparinized plasma and serum are acceptable for these assays where significant differences were found.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Protein Clinical chemistry/auto analyzer
    Electrolyte/Metal Clinical chemistry/auto analyzer
    Small molecule Clinical chemistry/auto analyzer
    Steroid Clinical chemistry/auto analyzer
    Carbohydrate Clinical chemistry/auto analyzer
    Lipoprotein Clinical chemistry/auto analyzer
    Lipid Clinical chemistry/auto analyzer
    Glycoprotein Clinical chemistry/auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Clinical chemistry/auto analyzer Specific Technology platform Roche Modular P analyzer
    Vitros 950 analyzer
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Biospecimen Aliquots and Components Aliquot sequential collection 1st collection
    2nd collection

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...